Opiant Pharmaceuticals (OPNT) Tops Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Financial Fact:
Professional services: 7.11M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Professional services: 7.11M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Opiant Pharmaceuticals (NASDAQ: OPNT) reported Q3 EPS of $0.77, $0.85 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $10.21 million.
For earnings history and earnings-related data on Opiant Pharmaceuticals (OPNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
